Patents by Inventor Claudio Daniel Schteingart

Claudio Daniel Schteingart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oxytocin receptor agonists
    Patent number: 8748564
    Abstract: The present invention relates to oxytocin receptor agonist compounds, pharmaceutical compositions comprising the same, use of such compounds for the manufacture of a medicament for treatment of inter alia, abdominal pain, irritable bowel syndrome (IBS), autism, erectile dysfunction, female sexual dysfunction, labor induction and maintenance, lactation induction and maintenance, postpartum hemorrhage, Post Traumatic Stress Disorder (PTSD), pain, anxiety and other conditions, as well as to methods for the treatment of such conditions, wherein such compounds are administered.
    Type: Grant
    Filed: September 21, 2010
    Date of Patent: June 10, 2014
    Assignee: Ferring B.V.
    Inventors: Kazimierz Wisniewski, Claudio Daniel Schteingart, Sudarkodi Alagarsamy, Robert Galyean
  • Peptidic GLP-2 agonists
    Patent number: 8580918
    Abstract: Novel GLP-2 analogs with improved pharmacokinetic properties are described as well as their use in the treatment of disease.
    Type: Grant
    Filed: October 21, 2010
    Date of Patent: November 12, 2013
    Assignee: Ferring B.V.
    Inventors: Sudarkodi Alagarsamy, Guangcheng Jiang, Pierre Riviere, Claudio Daniel Schteingart, Javier Sueiras-Diaz, Kazimierz Wisniewski
  • PEPTIDIC GLP-2 AGONISTS
    Publication number: 20120231999
    Abstract: Novel GLP-2 analogs with improved pharmacokinetic properties are described as well as their use in the treatment of disease.
    Type: Application
    Filed: October 21, 2010
    Publication date: September 13, 2012
    Applicant: FERRING B.V.
    Inventors: Sudarkodi Alagarsamy, Guangcheng Jiang, Pierre Riviere, Claudio Daniel Schteingart, Javier Sueiras-Diaz
  • OXYTOCIN RECEPTOR AGONISTS
    Publication number: 20120214733
    Abstract: The present invention relates to oxytocin receptor agonist compounds, pharmaceutical compositions comprising the same, use of such compounds for the manufacture of a medicament for treatment of inter alia, abdominal pain, irritable bowel syndrome (IBS), autism, erectile dysfunction, female sexual dysfunction, labor induction and maintenance, lactation induction and maintenance, postpartum hemorrhage, Post Traumatic Stress Disorder (PTSD), pain, anxiety and other conditions, as well as to methods for the treatment of such conditions, wherein such compounds are administered.
    Type: Application
    Filed: September 21, 2010
    Publication date: August 23, 2012
    Applicant: FERRING INTERNATIONAL CENTER S.A.
    Inventors: Kazimierz Wisniewski, Claudio Daniel Schteingart, Sudarkodi Alagarsamy, Robert Galyean
  • USE OF V2 RECEPTOR ANTAGONISTS IN COMBINATION WITH VASO PRESSINERGIC AGNOSTS
    Publication number: 20100311642
    Abstract: The combination of vasopressin V2 receptor antagonists and vasopressin receptor agonists (selective or non-selective) is described, including pharmaceutical compositions, including kits, for administering, and methods and uses of such a combination, e.g. for treatment of critical care diseases and conditions requiring control of arterial blood pressure or for treatment of hypotension.
    Type: Application
    Filed: September 25, 2008
    Publication date: December 9, 2010
    Applicant: Ferring B.V.
    Inventors: Pierre J-m.Riviere, Sudar Alagarsamy, Claudio Daniel Schteingart, Regent Laporte